Can Sponsors Contract Service Providers for Investigator Tasks?
EMA's GCP Inspectors Working Group (IWG) recently revised Question & Answer No. 11 in the section "GCP matters" of the Good Clinical Practice (GCP) Q&As.
Is it allowed that the sponsor could contract service providers to conduct trial-related tasks, procedures, duties and functions that are under the responsibility of the investigator?
Based on the trial design and setting, the sponsor may support the investigator by contracting service providers or personnel to be involved directly in the conduct of the clinical trial. In the opinion of the GCP IWG this is possible, provided the approach is compliant with the applicable EU laws and with the ICH E6 guideline requirements. There are aspects that need to be carefully considered to ensure that the division of roles of the responsible parties is maintained (see also the Recommendation paper on Decentralized Elements in Clinical Trials).
However, it is emphasized that the investigator is still responsible for any outsourced tasks involving trial-related medical decisions and the appropriate supervision of the persons or parties undertaking the activities delegated. Any trial related procedure that is delegated to a service provider should be specified in a written agreement. Where the agreement is between the sponsor and the service provider and involves tasks under investigator responsibility, it should be clear in the respective agreements (i.e. sponsor/service provider, sponsor/investigator) that the investigator maintains adequate control and oversight over the contracted tasks.
For more information please see EMA's Q&A: Good clinical practice (GCP).
Related GMP News
05.12.2024ICH E6(R3) Annex 2 Draft Guideline Released
05.12.2024ICH M15 Draft Guideline on Model-Informed Drug Development
07.11.2024Interim-Report on EMA's Clinical Study Data Proof-of-Concept Pilot
07.11.2024FDA Issues Guidances to Support Clinical Trial Innovation
17.10.2024FDA's final Q&A Document on Electronic Systems & Data in Clinical Trials
17.10.2024EMA Guideline on Quality and Equivalence of Topical Products